[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:chronic-sinusitis":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":93,"states":94},"Chronic Sinusitis",13,9,[8,16,23,29,36,42,48,54,60,66,74,80,87],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT05427695","Topical Probiotic Sinus Irrigations for Treating Chronic Sinusitis",[12],"Phase 2","RECRUITING","2026-08-26T02:15:13.282904Z","2026-05-05T02:43:29.070732Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT03439865","Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis",[20],"Early Phase 1","2026-08-26T02:15:23.202838Z","2026-05-05T02:43:28.284272Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07290140","Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis",[],"2026-08-26T02:16:50.548894Z","2026-05-05T02:43:27.319616Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT06996951","Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy",[33],"Phase 3","2026-08-26T02:15:26.669629Z","2026-05-05T02:43:27.178230Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT07299474","Efficacy of Lavender Aromatherapy on Anxiety and Pain Reduction During Awake Otolaryngologic Procedures",[],"2026-08-26T02:18:07.037408Z","2026-05-05T02:43:28.358255Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":46,"content_modified":47},"NCT06970977","CRS Questionnaire Validation Project",[],"2026-08-26T02:16:40.941792Z","2026-05-13T02:55:06.601067Z",{"nct_id":49,"title":50,"phases":51,"status":13,"updated_at":52,"content_modified":53},"NCT04469439","Impact of Sinus Surgery on Individuals With Cystic Fibrosis",[],"2026-08-26T02:15:53.461103Z","2026-05-13T02:55:06.249857Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT02038166","Nasal Potential Difference (NPD) Protocol in Chronic Rhinosinusitis",[],"2026-08-26T02:16:09.452956Z","2026-05-13T02:55:06.080958Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT06191640","Sinus Disease in Young Children With Cystic Fibrosis",[],"2026-08-26T02:18:57.189473Z","2026-05-13T02:55:06.427012Z",{"nct_id":67,"title":68,"phases":69,"status":71,"updated_at":72,"content_modified":73},"NCT07270302","Nebulized Nasal Steroids",[70],"Phase 1\u002FPhase 2","NOT_YET_RECRUITING","2026-08-26T02:18:01.700186Z","2026-05-05T02:43:28.296020Z",{"nct_id":75,"title":76,"phases":77,"status":71,"updated_at":78,"content_modified":79},"NCT07599826","Active vs. Passive VR During Office-based ENT Procedures",[],"2026-08-26T02:17:25.718160Z","2026-05-29T15:36:40.218630Z",{"nct_id":81,"title":82,"phases":83,"status":84,"updated_at":85,"content_modified":86},"NCT07286201","Evaluation of the Safety and Performance of a Bioresorbable Nasal Dressing Containing Mometasone Furoate (MF)",[],"ENROLLING_BY_INVITATION","2026-08-26T02:19:11.399072Z","2026-07-05T03:45:20.250034Z",{"nct_id":88,"title":89,"phases":90,"status":84,"updated_at":91,"content_modified":92},"NCT07010679","Treatment Decision-Making Among Patients With Chronic Rhinosinusitis",[],"2026-08-26T02:18:26.129155Z","2026-06-16T05:54:07.848779Z",[],[95,99,103,107,110,113],{"state":96,"count":97,"slug":98},"California",6,"california",{"state":100,"count":101,"slug":102},"Colorado",4,"colorado",{"state":104,"count":105,"slug":106},"Alabama",3,"alabama",{"state":108,"count":105,"slug":109},"Illinois","illinois",{"state":111,"count":105,"slug":112},"South Carolina","south-carolina",{"state":114,"count":105,"slug":115},"Virginia","virginia"]